|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net income (loss) | |||||
| Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: | |||||
| Change in fair value of financial instruments | |||||
| Change in fair value of loans | |||||
| Change in fair value of servicing assets | |||||
| Change in fair value of servicing liabilities | |||||
| Change in fair value of beneficial interest assets | |||||
| Change in fair value of beneficial interest liabilities | |||||
| Change in fair value of other financial instruments | |||||
| Total change in fair value of financial instruments | |||||
| Stock-based compensation | |||||
| Gain on loan servicing rights, net | |||||
| Gain on debt extinguishment | |||||
| Depreciation and amortization | |||||
| Loan premium amortization | |||||
| Non-cash interest expense and other | |||||
| Net changes in operating assets and liabilities: | |||||
| Purchases of loans held-for-sale | |||||
| Proceeds from sale of loans held-for-sale | |||||
| Principal payments received for loans held-for-sale | |||||
| Principal payments received for loans held by consolidated securitization | |||||
| Settlements of beneficial interest liabilities, net | |||||
| Proceeds from beneficial interest assets (derivatives) | |||||
| Settlements of beneficial interest assets (derivatives) | |||||
| Other assets | |||||
| Operating lease liability and right-of-use asset | |||||
| Accounts payable | |||||
| Payable to investors | |||||
| Payable to investors for beneficial interest assets | |||||
| Accrued expenses and other liabilities | |||||
| Net cash provided by (used in) operating activities | |||||
| Cash flows from investing activities | |||||
| Purchases and originations of loans held-for-investment | |||||
| Proceeds from sale of loans held-for-investment | |||||
| Principal payments received for loans held-for-investment | |||||
| Principal payments received for notes receivable and repayments of residual certificates | |||||
| Settlements of beneficial interest assets | |||||
| Acquisition and settlements of beneficial interest assets (hybrid instruments) | |||||
| Proceeds from beneficial interest assets (hybrid instruments) | |||||
| Issuance of line of credit receivable | |||||
| Repayments of line of credit receivable | |||||
| Purchases of property and equipment | |||||
| Capitalized software costs | |||||
| Acquisition of beneficial interest assets | |||||
| Purchases of non-marketable equity securities | |||||
| Purchase of certificates of deposit | |||||
| Acquisition, net of cash acquired | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities | |||||
| Proceeds from borrowings | |||||
| Proceeds from convertible notes issuance, net of debt issuance costs paid to lender | |||||
| Payment of debt issuance costs to third parties | |||||
| Repayments of borrowings | |||||
| Payments for repurchases of convertible notes | |||||
| Purchase of capped calls | |||||
| Settlement of capped calls | |||||
| Principal payments made on securitization notes | |||||
| Payable to investors | |||||
| Proceeds from issuance of securitization notes | |||||
| Proceeds from secondary offering, net of underwriting discounts, commissions, and offering costs | |||||
| Proceeds from issuance of common stock under employee stock purchase plan | |||||
| Proceeds from exercise of stock options | |||||
| Taxes paid related to net share settlement of equity awards | |||||
| Repurchases of common stock | |||||
| Net proceeds related to stock-based award activities | |||||
| Net cash provided by financing activities | |||||
| Change in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash at beginning of year | |||||
| Cash, cash equivalents and restricted cash at end of year | |||||
| Supplemental disclosures of cash flow information | |||||
| Cash paid for interest | |||||
| Cash paid for amounts included in the measurement of lease liabilities | |||||
| Cash paid for income taxes, net | |||||
| Supplemental disclosures of non-cash investing and financing activities | |||||
| Beneficial interests obtained in connection with loan sales | |||||
| Securities retained under unconsolidated securitization transactions | |||||
| Issuance of line of credit receivable | |||||
| Capitalized stock-based compensation expense | |||||
| Issuance of common stock in connection with acquisition | |||||
| Issuance costs of new convertible notes | |||||
| Repayments of line of credit receivable | |||||
| Settlement of borrowings in connection with loan sale | |||||
| Securities retained under consolidated securitization transaction | |||||
| Beneficial interest assets included in payable to investors | |||||
| Cash and Restricted Cash | |||||
| Cash | |||||
| Cash and cash equivalents | |||||
| Restricted cash | |||||
Loading...